Clario and PathAI collaborate to deliver integrated solution for GI clinical trials

Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders

24 Oct 2024

Clario, a leading provider of endpoint data solutions to the clinical trials industry, has announced a strategic partnership with PathAI, a leader in AI-powered digital pathology solutions aimed at improving diagnostic accuracy and efficiency. This collaboration offers a single-vendor solution for efficient anatomical pathology services and next-generation video endoscopy analysis.

This co-delivery model streamlines endoscopic and histopathology endpoints to improve efficiency in global GI studies. CROs and sponsors will benefit from an end-to-end process that covers training, logistics, tissue processing, slide digitization, image analysis, and data transfers all with expert medical and scientific oversight. Sites will experience simplified workflows with improved training, reporting, and document management.

Clario has extensive experience in GI trials, having supported over 130 studies through advanced imaging solutions like endoscopy, MRI, and ultrasound. Clario scientists and technologies help reduce site burden and enhance trial efficiency with AI-supported reading for UC and HD-video endoscopy support.

PathAI bolsters the partnership with its expert GI pathologist network and cutting-edge anatomical pathology services while optimizing specimen handling and histological assessments. PathAI's AI-powered tools enhance UC assessment, minimize variability in histological scoring, and expedite biomarker discovery.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags